First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions

Asthma

Interventions

DRUG

SAR443765

solution for injection

DRUG

Placebo

solution for injection

DRUG

Salbutamol or levosalbutamol

metered dose inhaler

Trial Locations (2)

Investigational Site Number : 2760001, Berlin

Investigational Site Number : 8260001, Belfast